Shigella

Shigella is a genus of Gram-negative, facultatively anaerobic bacteria in the family Enterobacteriaceae, closely related to Escherichia coli — so closely that many 16S rRNA-based studies report them as the Escherichia/Shigella complex, unable to distinguish the two genera at the amplicon level. Shigella species (S. dysenteriae, S. flexneri, S. sonnei, S. boydii) are the causative agents of bacillary dysentery and are among the most invasive enteric pathogens, capable of penetrating and destroying colonic epithelial cells.

In the WikiBiome framework, Shigella is notable for two reasons: its metal-dependent virulence (iron and nickel requirements that make it vulnerable to nutritional immunity) and its frequent appearance as part of the Escherichia/Shigella bloom that characterizes dysbiosis across dozens of disease signatures.

Metal Dependencies

Iron — Siderophore Arsenal

Shigella possesses multiple iron acquisition systems, reflecting the critical importance of iron for its intracellular survival and replication:

  • Enterobactin: The primary catecholate siderophore shared with E. coli, with the highest known Fe3+ binding affinity (Kd ~10^-49 M). Countered by host lipocalin 2 [1].
  • Aerobactin: A hydroxamate siderophore that evades lipocalin-2 neutralization, providing a backup iron acquisition system when enterobactin is blocked.
  • Heme uptake: Shigella can acquire iron directly from host hemoglobin and heme proteins during tissue invasion.

Iron availability in the gut directly affects Shigella virulence — iron supplementation in endemic regions has been associated with increased dysentery severity, while host hepcidin-driven iron sequestration during infection represents nutritional immunity against Shigella (Karen's Brain Primitive 2).

Nickel

Shigella flexneri harbors nickel-dependent enzymes relevant to its acid resistance and survival during gastric transit [1]. The nickel connection links Shigella to the broader pattern of nickel-dependent enteric pathogens in this wiki.

Key Virulence Factors

  • Type III secretion system (T3SS): Encoded on the virulence plasmid; injects effector proteins (IpaB, IpaC, IpaD) into host epithelial cells to trigger bacterial uptake and intracellular spread.
  • IcsA/VirG: Surface protein enabling actin-based motility within host cells — Shigella propels itself through the cytoplasm and spreads directly to adjacent cells without extracellular exposure.
  • Shiga toxin: Produced by S. dysenteriae type 1; inhibits protein synthesis; causes hemorrhagic colitis and hemolytic uremic syndrome (HUS).
  • LPS endotoxin: Drives the intense inflammatory response characteristic of shigellosis.

The Escherichia/Shigella Complex in Dysbiosis

Because 16S rRNA sequencing cannot reliably distinguish Escherichia from Shigella, most microbiome studies report an Escherichia/Shigella operational taxonomic unit. This complex is one of the most consistently enriched taxa across disease signatures in this wiki:

  • Endometriosis: Escherichia/Shigella enriched in cervical samples of endometriosis patients, with decreased Gardnerella, Atopobium, and Megasphaera [2] [3] [4].
  • Inflammatory bowel disease: Enrichment of Escherichia/Shigella is one of the most reproducible IBD microbiome findings, driven by inflammation-associated iron availability favoring siderophore producers [5] [6] [7].
  • Heart failure: Part of the Enterobacteriaceae bloom in decompensated heart failure [8] [9].
  • ASD: Enrichment reported in altered gut microbiota of ASD children [10].
  • CKD: Escherichia/Shigella enrichment associated with metalloid resistance genes in CKD gut microbiome [11].
  • Estrogen recirculation: Escherichia/Shigella species possess beta-glucuronidase activity, contributing to estrogen deconjugation in the estrobolome [12].

Metal-Antibiotic Resistance

Shigella species, like other Enterobacteriaceae, carry metal resistance genes co-located with antibiotic resistance determinants on mobile genetic elements. Environmental metal exposure selects for multidrug-resistant Shigella strains — a direct example of the co-selection paradigm [11] [13].

Cross-References

  • escherichia coli — phylogenetically near-identical; reported together in most 16S studies
  • adherent invasive e coli — shares iron-dependent invasive strategy
  • iron — siderophore-dependent virulence; nutritional immunity target
  • siderophores — enterobactin and aerobactin as primary iron acquisition systems
  • nickel — nickel-dependent acid resistance
  • lipocalin 2 — host counter-siderophore defense
  • estrobolome — beta-glucuronidase activity contributes to estrogen recirculation
  • co selection — metal and antibiotic resistance on shared mobile elements
  • enterobacteriaceae — family-level enrichment in dysbiosis across conditions

References (14)

  1. Robert J. Maier, Stéphane L. Benoit (2019). Role of Nickel in Microbial Pathogenesis. Inorganics. doi:10.3390/inorganics7070080
  2. Baris Ata, Sule Yildiz, Engin Turkgeldi et al. (2019). Ata 2019 — The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Scientific Reports. doi:10.1038/s41598-019-39700-6
  3. Chloe Hicks, Mathew Leonardi, Xin-Yi Chua et al. (2025). Hicks et al. 2025 — Oral, Vaginal, and Stool Microbial Signatures in Patients With Endometriosis as Potential Diagnostic Non-Invasive Biomarkers. BJOG: An International Journal of Obstetrics and Gynaecology. doi:10.1111/1471-0528.17979
  4. Hooi-Leng Ser, Siu-Jung Au Yong, Mohamad Nasir Shafiee et al. (2023). Ser 2023 — Current Updates on the Role of Microbiome in Endometriosis: A Narrative Review. Microorganisms. doi:10.3390/microorganisms11020360
  5. Haijing Wang, Yuanjun Wang, Libin Yang et al. (2024). Wang 2024 — Integrated 16S rRNA sequencing and metagenomics insights into microbial dysbiosis and distinct virulence factors in inflammatory bowel disease. Frontiers in Microbiology. doi:10.3389/fmicb.2024.1375804
  6. Kang DY, Park JL, Yeo MK et al. (2023). Diagnosis of Crohn's Disease and Ulcerative Colitis Using the Microbiome. BMC Microbiology. doi:10.1186/s12866-023-03084-5
  7. Cronin P, McCarthy S, Hurley C et al. (2023). Comparative Diet-Gut Microbiome Analysis in Crohn's Disease and Hidradenitis Suppurativa. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1289374
  8. Tomohiro Hayashi, Tomoya Yamashita, Hikaru Watanabe et al. (2019). Gut Microbiome and Plasma Microbiome-Related Metabolites in Patients With Decompensated and Compensated Heart Failure. Circulation Journal. doi:10.1253/circj.CJ-18-0468
  9. Jing Gao, Kun-Tao Yan, Ji-Xiang Wang et al. (2020). Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Scientific Reports. doi:10.1038/s41598-020-59235-5
  10. Francesco Strati, Duccio Cavalieri, Davide Albanese et al. (2017). Strati 2017 — New Evidences on the Altered Gut Microbiota in Autism Spectrum Disorders. Microbiome. doi:10.1186/s40168-017-0242-1
  11. María V. Miranda, Fernanda C. González, Osvaldo S. Paredes-Godoy et al. (2022). Miranda 2022 — Characterization of Metal(loid)s and Antibiotic Resistance in Bacteria of Human Gut Microbiota from CKD Subjects. Biological Research. doi:10.1186/s40659-022-00389-z
  12. Kanakaraju Kaliannan, Ruairi C. Robertson, Kiera Murphy et al. (2018). Kaliannan et al. 2018 — Estrogen-Mediated Gut Microbiome Alterations Influence Sexual Dimorphism in Metabolic Syndrome in Mice. Microbiome. doi:10.1186/s40168-018-0587-0
  13. Qinheng Zhu, Boyan Chen, Fu Zhang et al. (2024). Toxic and Essential Metals: Metabolic Interactions with the Gut Microbiota and Health Implications. Frontiers in Nutrition. doi:10.1016/j.biopha.2023.115602
  14. Khan F, Rizvi M, Shukla I et al. (2011). A Novel Approach for Identification of Members of Enterobacteriaceae Isolated from Clinical Samples. Biology and Medicine